

Prospect Capital vs Oaktree Specialty Lending
Prospect Capital lends to middle-market companies and has historically relied on equity co-investments and CLO management to supplement interest income, while Oaktree Specialty Lending benefits from the brand and deal flow of Oaktree Capital Management to source senior secured loans to similar borrowers. Both are externally managed BDCs paying out most of their net investment income as dividends, making distribution coverage the central question for income-seeking investors. The Prospect Capital vs Oaktree Specialty Lending comparison lays out how credit quality, portfolio composition, and management fee structures differentiate two seemingly similar lenders targeting the same middle-market borrower base.
Prospect Capital lends to middle-market companies and has historically relied on equity co-investments and CLO management to supplement interest income, while Oaktree Specialty Lending benefits from t...
Investment Analysis

Prospect Capital
PSEC
Pros
- Consistently maintains a high forward dividend yield above 16%, providing robust income appeal in a low-yield environment.
- Strategic shift focusing on first lien senior secured middle market loans has increased first lien exposure to 71.1%, reducing risk from lower-quality debt.
- Recent quarterly earnings per share (EPS) significantly exceeded expectations, indicating improving profitability dynamics.
Considerations
- Reported annual revenue declined by over 16% with recent quarters showing continued top-line weakness.
- The company has been unprofitable over the last twelve months with a negative trailing EPS of -$1.35.
- Analyst consensus is bearish with price targets lower than current trading levels, reflecting concerns about future growth and valuation.
Pros
- Specializes in lending and investment services to small and mid-sized companies, targeting a niche market segment.
- Reported a net margin close to 24%, indicating efficient cost management relative to revenue.
- Stable management with no promoter pledging and recent stock price demonstrating modest positive momentum.
Considerations
- Latest financials show zero reported profit after tax, indicating lack of recent profitability.
- Return on equity is low, at approximately 3.7%, suggesting limited shareholder value generation currently.
- Operating margin is moderate at 14.2%, which may constrain growth potential compared to peers with higher margins.
Related Market Insights
Private Market Liquidity: Could Goldman's Move Signal a Shift?
Goldman Sachs' acquisition of Industry Ventures highlights the booming private market liquidity and venture capital secondary market. Explore investment opportunities in this evolving financial landscape.
Aimee Silverwood | Financial Analyst
October 14, 2025
The Dividend Hunter's Dilemma: Why High-Yield Stocks Deserve Your Attention
Explore high-yield dividend stocks for income. Learn about top performers like IEP, OXLC, MNR, and manage risks. Invest smart with Nemo's fractional shares & AI insights.
Aimee Silverwood | Financial Analyst
July 25, 2025
Expert-Backed Future Stars: The Smart Money's Next Big Bets
Discover Nemo's Expert-Backed Future Stars Neme. Invest in innovative companies validated by VCs & financial experts. Access AI-driven fintech, biotech, & growth firms with fractional shares.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Private Market Liquidity: Could Goldman's Move Signal a Shift?
Goldman Sachs' acquisition of Industry Ventures highlights the booming private market liquidity and venture capital secondary market. Explore investment opportunities in this evolving financial landscape.
Aimee Silverwood | Financial Analyst
October 14, 2025
The Dividend Hunter's Dilemma: Why High-Yield Stocks Deserve Your Attention
Explore high-yield dividend stocks for income. Learn about top performers like IEP, OXLC, MNR, and manage risks. Invest smart with Nemo's fractional shares & AI insights.
Aimee Silverwood | Financial Analyst
July 25, 2025
Expert-Backed Future Stars: The Smart Money's Next Big Bets
Discover Nemo's Expert-Backed Future Stars Neme. Invest in innovative companies validated by VCs & financial experts. Access AI-driven fintech, biotech, & growth firms with fractional shares.
Aimee Silverwood | Financial Analyst
July 25, 2025
Corporate Dragons: The Fortress Companies That Laugh at Economic Storms
Discover Nemo's Corporate Dragons Neme: invest in cash-rich, low-debt fortress companies built to thrive in any economic storm. Start with fractional shares.
Aimee Silverwood | Financial Analyst
July 25, 2025
Complexity Kings: When Opacity Creates Opportunity
Discover Nemo's Complexity Kings Neme. Invest in companies with opaque structures and hidden value, poised for significant returns as economic pressures force simplification.
Aimee Silverwood | Financial Analyst
July 25, 2025
Banks in Private Credit: The Trillion-Dollar Lending Revolution
Explore how banks are transforming the trillion-dollar private credit market. Invest in high-yielding BDCs & credit funds with Nemo. Access fractional shares from $1.
Aimee Silverwood | Financial Analyst
July 25, 2025
Which Baskets Do They Appear In?
Private Market Liquidity: Could Goldman's Move Signal?
Goldman Sachs' acquisition of Industry Ventures for nearly $1 billion signals a strategic push by major financial players into the growing venture capital secondary market. This development suggests a broader investment opportunity among asset managers and service providers poised to benefit from the increasing demand for liquidity in private markets.
Published: October 14, 2025
Explore BasketBanks in Private Credit
This carefully selected group of stocks captures the trillion-dollar shift as traditional banks enter the private lending arena. Our professional analysts have identified key Business Development Companies (BDCs) and specialized funds that stand to benefit from this growing financial trend.
Published: July 15, 2025
Explore BasketExpert-Backed Future Stars
This collection features emerging companies that have earned strong backing from financial experts and analysts. These carefully selected stocks represent innovative businesses with exceptional growth potential, positioned to become the market leaders of tomorrow.
Published: June 18, 2025
Explore BasketWhich Baskets Do They Appear In?
Private Market Liquidity: Could Goldman's Move Signal?
Goldman Sachs' acquisition of Industry Ventures for nearly $1 billion signals a strategic push by major financial players into the growing venture capital secondary market. This development suggests a broader investment opportunity among asset managers and service providers poised to benefit from the increasing demand for liquidity in private markets.
Published: October 14, 2025
Explore BasketBanks in Private Credit
This carefully selected group of stocks captures the trillion-dollar shift as traditional banks enter the private lending arena. Our professional analysts have identified key Business Development Companies (BDCs) and specialized funds that stand to benefit from this growing financial trend.
Published: July 15, 2025
Explore BasketExpert-Backed Future Stars
This collection features emerging companies that have earned strong backing from financial experts and analysts. These carefully selected stocks represent innovative businesses with exceptional growth potential, positioned to become the market leaders of tomorrow.
Published: June 18, 2025
Explore BasketComplexity Kings
Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.
Published: June 17, 2025
Explore BasketCorporate Dragons: The Fortresses
Meet the financial titans built on massive cash reserves and minimal debt. These carefully selected companies offer exceptional stability during economic turbulence, giving your portfolio a strong defensive anchor when markets get rough.
Published: June 17, 2025
Explore BasketHigh Yielding Stocks
Looking for income from your investments? These carefully selected companies have historically paid substantial dividends compared to their share prices. Our analysts have handpicked these stocks for their dividend potential.
Published: May 7, 2025
Explore BasketBuy PSEC or OCSL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons


Prospect Capital vs ProAssurance
Prospect Capital deploys capital as a business-development company hunting yield in middle-market credit, while ProAssurance writes specialty liability insurance and sits on the other side of risk entirely. Prospect Capital vs ProAssurance both offer income-oriented appeal to shareholders, but their balance-sheet structures, regulatory frameworks, and earnings volatility couldn't be more different. Find out which company's dividend looks more durable when credit cycles or loss reserves turn ugly.


QCR Holdings vs Oaktree Specialty Lending
QCR Holdings operates community and commercial banks across Midwest markets where it's built solid deposit franchises alongside a commercial equipment leasing unit, while Oaktree Specialty Lending deploys capital into middle-market companies through first and second lien loans backed by one of the world's most respected credit franchises. Both channel capital into businesses that can't easily tap public markets, yet they do it under very different risk tolerances, regulatory frameworks, and liquidity profiles that shape how investors should think about each. The QCR Holdings vs Oaktree Specialty Lending comparison lays out how credit quality, balance sheet leverage, loan yields, and fee structures stack up across these two very different lending-oriented financial businesses.


ProAssurance vs Oaktree Specialty Lending
ProAssurance writes medical professional liability and workers' compensation insurance serving healthcare providers who need specialty coverage for clinical risk, while Oaktree Specialty Lending is a business development company deploying capital into middle-market loans to generate income for shareholders. Both companies earn returns by pricing and managing risk that mainstream financial institutions often avoid or underprice. The ProAssurance vs Oaktree Specialty Lending comparison explores how specialty insurance underwriting and direct lending returns stack up in terms of income consistency and credit cycle sensitivity.